ENTBF
Price
$0.20
Change
-$0.00 (-0.00%)
Updated
Jan 16 closing price
Capitalization
1.66M
HLOSF
Price
$0.96
Change
-$0.39 (-28.89%)
Updated
Jan 2 closing price
Capitalization
136.32M
Ad is loading...

ENTBF vs HLOSF

Header iconENTBF vs HLOSF Comparison
Open Charts ENTBF vs HLOSFBanner chart's image
ENTHEON BIOMEDICAL
Price$0.20
Change-$0.00 (-0.00%)
Volume$1.02K
Capitalization1.66M
HEALIOS K K
Price$0.96
Change-$0.39 (-28.89%)
Volume$100
Capitalization136.32M
ENTBF vs HLOSF Comparison Chart
Loading...
ENTBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTBF vs. HLOSF commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTBF is a Hold and HLOSF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ENTBF: $0.20 vs. HLOSF: $0.96)
Brand notoriety: ENTBF and HLOSF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTBF: 36% vs. HLOSF: 2%
Market capitalization -- ENTBF: $1.66M vs. HLOSF: $136.32M
ENTBF [@Biotechnology] is valued at $1.66M. HLOSF’s [@Biotechnology] market capitalization is $136.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTBF’s FA Score shows that 0 FA rating(s) are green whileHLOSF’s FA Score has 0 green FA rating(s).

  • ENTBF’s FA Score: 0 green, 5 red.
  • HLOSF’s FA Score: 0 green, 5 red.
According to our system of comparison, ENTBF is a better buy in the long-term than HLOSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTBF’s TA Score shows that 3 TA indicator(s) are bullish while HLOSF’s TA Score has 2 bullish TA indicator(s).

  • ENTBF’s TA Score: 3 bullish, 3 bearish.
  • HLOSF’s TA Score: 2 bullish, 2 bearish.
According to our system of comparison, HLOSF is a better buy in the short-term than ENTBF.

Price Growth

ENTBF (@Biotechnology) experienced а +3.38% price change this week, while HLOSF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLOSF($136M) has a higher market cap than ENTBF($1.66M). ENTBF YTD gains are higher at: 49.097 vs. HLOSF (-28.889). ENTBF has higher annual earnings (EBITDA): -323.3K vs. HLOSF (-2.39B). HLOSF has more cash in the bank: 8.89B vs. ENTBF (229K). HLOSF has higher revenues than ENTBF: HLOSF (521M) vs ENTBF (0).
ENTBFHLOSFENTBF / HLOSF
Capitalization1.66M136M1%
EBITDA-323.3K-2.39B0%
Gain YTD49.097-28.889-170%
P/E RatioN/AN/A-
Revenue0521M-
Total Cash229K8.89B0%
Total DebtN/A6.1B-
TECHNICAL ANALYSIS
Technical Analysis
ENTBFHLOSF
RSI
ODDS (%)
N/A
Bullish Trend 12 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
90%
N/A
Momentum
ODDS (%)
N/A
Bearish Trend 12 days ago
21%
MACD
ODDS (%)
Bullish Trend 12 days ago
90%
Bearish Trend 12 days ago
43%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
87%
Bearish Trend 12 days ago
35%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
85%
Bearish Trend 12 days ago
24%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend about 1 month ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 12 days ago
90%
Bullish Trend 12 days ago
25%
View a ticker or compare two or three
Ad is loading...
ENTBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSCI3.000.11
+3.81%
COSCIENS Biopharma Inc
CFFI74.122.65
+3.71%
C&F Financial Corp
STGW6.530.21
+3.32%
Stagwell
ACM108.931.08
+1.00%
Aecom
BANF119.750.95
+0.80%
BancFirst Corp

ENTBF and

Correlation & Price change

A.I.dvisor tells us that ENTBF and AVTE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ENTBF and AVTE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTBF
1D Price
Change %
ENTBF100%
N/A
AVTE - ENTBF
32%
Poorly correlated
+6.17%
OVID - ENTBF
23%
Poorly correlated
+1.37%
IMRN - ENTBF
22%
Poorly correlated
+8.59%
HSTC - ENTBF
22%
Poorly correlated
N/A
ATNF - ENTBF
21%
Poorly correlated
-1.27%
More

HLOSF and

Correlation & Price change

A.I.dvisor tells us that HLOSF and BRTX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLOSF and BRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLOSF
1D Price
Change %
HLOSF100%
N/A
BRTX - HLOSF
23%
Poorly correlated
-2.72%
LGVN - HLOSF
22%
Poorly correlated
-3.41%
ENTBF - HLOSF
7%
Poorly correlated
N/A
CPMV - HLOSF
5%
Poorly correlated
N/A
SLN - HLOSF
3%
Poorly correlated
+1.79%
More